A. Delgado

The PROMISE Study: PROphylaxis of Migraine with SEglor® (Dihydroergotamine Mesilate) in French Primary Care

A. Pradalier, M. Lanteri-Minet, G. Géraud, 2004, CNS drugs.

Opinions of French patients with schizophrenia regarding injectable medication

A. Delgado, F. Caroli, P. Raymondet, 2011, Patient preference and adherence.

A randomized, double-blind trial assessing the efficacy and safety of sublingual metopimazine and ondansetron in the prophylaxis of chemotherapy-induced delayed emesis

J. Chidiac, M. di Palma, O. Bensaoula, 2006, Anti-cancer drugs.

Compliance with the clinical guidelines for managing asthma by primary care physicians: An ambispective observational study.

Maria-Esther Vidal, R. Villalba, José Ribelles, 2020, Revista clinica espanola.

Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy

D. Khayat, O. Rixe, J. Bloch, 2005, Current medical research and opinion.

[Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].

D. Misdrahi, D. Comet, S. Bouju, 2013, L'Encephale.